Release time：Nov 16, 2022
The main forum of "International Biopharma Industry Week Shanghai 2022 - Zhangjiang Life Science International Innovation Summit" was officially opened on November 15, 2022, during which the first "Zhangjiang Life Science Industry New Prominent" award was released. Mabwell won the "Zhangjiang Life Science Industry New Prominent · 2022".
For the development of biopharma industry in Pudong, talents are the greatest advantages and enterprises are the core carriers. In order to encourage innovation and show vitality, the "Zhangjiang Life Science Industry New Prominent" award was established for the first time this year under the guidance and support of the Office of the Leading Group for Talent Work of Pudong New Area and the Pudong Science, Technology and Economic Commission, and the winners were selected by relevant parks and Shanghai Pudong Biology Industry Association under the organization of the organizing committee of Zhangjiang Life Science International Innovation Summit. This award focuses on prominent enterprises that have made new breakthroughs such as "new scientific discoveries, new technological inventions, new industrial directions and new development concepts" since 2021, promoting the spirit of innovation and highlighting the achievements of innovation. The awarded enterprises are all the biopharmaceutical innovation subjects that have made significant new breakthroughs in development since last year, showing the outstanding characteristics of strong innovation and rapid growth.
Zhangjiang has always been synonymous with the biopharmaceutical innovation in Shanghai. Mabwell, as an innovative biopharmaceutical enterprise rooted in Zhangjiang, persists in sustainable innovation, focuses on antibody molecules with national and even global competitive advantages, insists on making original new drugs with true clinical value, and contributes to the development of innovative drugs in China.
